An outbreak of coronavirus in New York could cause more sharp selling of stocks, but markets would likely continue to function even if the floor of the New York Stock Exchange had to close.
Novartis will officially spin its Alcon eye-care business off into a separately traded standalone business unit on April 9, 2019.
Eight PDUFA Dates to Watch in August 2017
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Biotech, Blood Cancers, Cardiovascular Deaths, Glaucoma, Head & Neck Cancer, Hepatitis C, Kidney Cancer, Melanoma, Nasdaq Biotech Index, New Molecular Entities, New York Stock Exchange, Parkinson's Disease, Prescription Drug User Fee Act (PDUFA), Rabies, StocksThe biotech industry did OK in July 2017. The NYSE ARCA Biotech Index and the iShares NASDAQ Biotechnology Index (ETF) grew about 1.9 percent and 2.9 percent, respectively last month. There have been 26 new molecular entity approvals so far this year. With that figure in mind, here are eight companies looking at PDUFA dates in August 2017.
Mallinckrodt Plc, one of the largest manufacturers of the generic opioid painkiller oxycodone, will pay $35 million to resolve allegations that it failed to report suspicious drug orders, the U.S. Justice Department said.
St. Jude Medical Inc. filed a lawsuit against short-selling firm Muddy Waters and cyber security company MedSec Holdings Ltd.
